AngioDynamics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
AngioDynamics, Inc. (ANGO) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $2.67 million as of 2026-02-28, per its 10-Q filed 2026-04-02.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-04-02
- 2026-02-28: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.67M.
- 2025-11-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $5.26M.
- 2025-08-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $7.84M.
- 2025-02-28: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.60M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-02-28 | $2.67M 10-Q · filed 2026-04-02 |
| 2025-11-30 | $5.26M 10-Q · filed 2026-01-06 |
| 2025-08-31 | $7.84M 10-Q · filed 2025-10-02 |
| 2025-02-28 | $2.60M 10-Q · filed 2025-04-02 |
| 2024-11-30 | $5.18M 10-Q · filed 2025-01-08 |
| 2024-08-31 | $7.77M 10-Q · filed 2024-10-03 |
| 2024-02-29 | $2.60M 10-Q · filed 2024-04-09 |
| 2023-11-30 | $7.19M 10-Q · filed 2024-01-08 |
| 2023-08-31 | $10.73M 10-Q · filed 2023-10-05 |
| 2023-02-28 | $5.92M 10-Q · filed 2023-03-31 |
| 2022-11-30 | $9.23M 10-Q · filed 2023-01-06 |
| 2022-08-31 | $14.13M 10-Q · filed 2022-10-11 |
| 2022-02-28 | $4.88M 10-Q · filed 2022-04-07 |
| 2021-11-30 | $9.80M 10-Q · filed 2022-01-07 |
| 2021-08-31 | $14.64M 10-Q · filed 2021-09-30 |
| 2021-02-28 | $4.22M 10-Q · filed 2021-03-31 |
| 2020-11-30 | $8.49M 10-Q · filed 2021-01-08 |
| 2020-08-31 | $13.75M 10-Q · filed 2020-10-07 |
| 2020-02-29 | $4.86M 10-Q · filed 2020-04-08 |
| 2019-11-30 | $9.51M 10-Q · filed 2020-01-08 |
| 2019-08-31 | $11.31M 10-Q · filed 2019-10-04 |
| 2019-02-28 | $5.17M 10-Q · filed 2019-04-02 |
| 2018-11-30 | $10.28M 10-Q · filed 2019-01-07 |
| 2018-08-31 | $13.46M 10-Q · filed 2018-10-01 |
| 2018-02-28 | $4.04M 10-Q · filed 2018-04-05 |
| 2017-11-30 | $8.26M 10-Q · filed 2018-01-05 |
| 2017-08-31 | $12.36M 10-Q · filed 2017-09-29 |
| 2017-02-28 | $4.40M 10-Q · filed 2017-04-03 |
| 2016-11-30 | $8.82M 10-Q · filed 2017-01-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |